Invesaro

Stocks KMT Financial statements

Financial statements

KENNAMETAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KENNAMETAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue2,0582,3682,3751,8851,8412,0122,0782,0471,9672,357
Cost of revenue1,4131,5481,5441,3561,2891,3641,4321,4201,3691,387
Gross profit645820831529552648646627598970
Research and development3838.93938.739.542.143.144.244.443.2
Selling, general and administrative433431479
Operating expenses469503474388407419437433431
Operating income94.829032922.3102218192170143473
Interest expense28.830.13335.246.425.928.526.524.928.6
Other non-operating income1614.815.414.98.8714.5-4.30.713.817.4
Pre-tax income81.92753111.9664.7207160144132461
Income tax29.97063.47.016.2456.536.330.833.3111
Net income to minority interests2.844.885.950.613.985.584.914.325.588.03
Net income49.1200242-5.6654.414511810993.1342
EBITDA202399441142229350326305280616
EPS, basic0.612.452.94-0.070.651.741.471.381.214.49
EPS, diluted0.612.422.90-0.070.651.721.461.371.204.42
Shares, basic (weighted)80.481.582.48383.683.380.879.477.376.2
Shares, diluted (weighted)81.282.883.38384.383.981.48077.977.4
Dividend per share0.800.800.800.800.800.800.800.800.800.80

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents19155618260715485.610612814195.8
Receivables380401380238303295307303295408
Inventory4885255725224765715585155381,108
Other current assets55.263.357.473.771.572.955.857.265.1159
Total current assets1,1141,5461,1911,4411,0051,0251,0271,0031,0391,772
Property, plant and equipment7448249351,0381,0551,002969938920844
Lease right-of-use assets04850.347.24348.145.245.8
Goodwill301302300271278264270272283279
Intangible assets19117616113312010693.281.467.255.9
Other non-current assets12.817.517.517.49.858.589.5412.625.5129
Total assets2,4152,9262,6563,0382,6662,5742,5472,5042,5453,167
Accounts payable216222213165178228203192196370
Accrued liabilities85.795.276.647.661.556.355.65355.667.9
Short-term debt03990
Total current liabilities461887462898437486434416422677
Long-term debt695592592594592594595596597685
Lease liabilities035.436.835.332.235.633.434.5
Other non-current liabilities2824.62134.432.215.422.7202121.1
Total liabilities1,3631,6951,2821,7691,2981,2821,2331,2151,2211,553
Total debt03990594592594595596597685
Paid-in capital475512529539563494465417374390
Retained earnings7669011,0771,0059931,0711,1251,1701,2021,483
Other comprehensive income-324-320-374-417-330-414-414-435-387-399
Shareholders' equity1,0171,1941,3351,2301,3301,2531,2751,2501,2841,570
Minority interests35.43639.538.938.638.738.738.740.743.6
Total equity1,0531,2301,3751,2691,3681,2911,3141,2891,3251,613
Total liabilities and equity2,4152,9262,6563,0382,6662,5742,5472,5042,5453,167

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income52205248-5.0558.415012311498.7350
Depreciation and amortization108109112120126132134135136143
Stock-based compensation21.120.822.81624.82124.724.322.134.9
Deferred income tax6.2722.92.81-23.9-21.211.3-9.22-8.02-13.144.7
Change in receivables-7.61-22.217.3129-53.3-14.4-11.5-2.629.07-117
Change in inventory-24.3-37.2-53.428.261.3-12717.636.8-17.4-593
Change in payables54.6-5.05-49.4-46.346.832-32.5-6.09-6.16226
Cash from operations195277301224236-181258277208-4.01
Capital expenditures-118-171-212-244-127-96.9-94.4-108-89-76.9
Acquisitions00-4.0100
Cash from investing-113-157-201-218-123-94.9-89.2-109-61.8-71.3
Debt issued25.3296002980000297
Debt repaid-25.9-0.19-4000-3000000-209
Share buybacks-0.24-0.22-0.21-0.21-0.2-85.5-49.3-65.6-60.1-10.1
Dividends paid-64.1-65.1-65.7-66.3-66.7-66.6-64.5-63.4-61.9-60.8
Cash from financing-53.3247-471425-574-151-143-142-13431.6
Exchange rate effect-0.26-2.11-1.74-6.188.9-4.23-5.17-3.99-0.01-1.08
Net change in cash29.1366-374425-453-68.520.42212.6-44.7
Free cash flow77.310688.2-20.4108-278164170119-80.9
Interest paid27.527.930.325.843.625.328.226.424.827.1
Income taxes paid16.83651.536.948.936.143.748.558.655.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $24.03 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin50.6%Gross profit / revenue.
Operating margin31.0%Operating income / revenue.
EBITDA margin36.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin29.9%Pre-tax income / revenue.
Net margin22.5%Net income / revenue.
FCF margin-10.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-8.5%Cash from operations / revenue.
Effective tax rate23.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)32.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)15.2%Net income / average total assets.
Return on invested capital (ROIC)23.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue18.8%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.5%Capital expenditures / revenue.
D&A / revenue5.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y19.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y62.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y230.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y34.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y35.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y120.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y23.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y21.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y267.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y42.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y44.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y268.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y44.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y46.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-101.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-167.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y0.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y22.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y7.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y3.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y24.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y7.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.45xCurrent assets / current liabilities.
Quick ratio0.96x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.37x(Cash + short-term investments) / current liabilities.
Debt / equity0.60xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets28.2%Total debt / total assets.
Liabilities / assets51.9%Total liabilities / total assets.
Net debt$821.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.86xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage24.1xOperating income / interest expense.
Working capital$1.79BCurrent assets - current liabilities.
Goodwill and intangibles / assets8.5%(Goodwill + intangible assets) / total assets.
Tangible book value$1.49BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.68xRevenue / average total assets.
Fixed asset turnover3.20xRevenue / average property, plant and equipment.
Inventory turnover0.80xCost of revenue / average inventory.
Days inventory454 days365 x average inventory / cost of revenue.
Receivables turnover6.11xRevenue / average receivables.
Days sales outstanding60 days365 x average receivables / revenue.
Days payables109 days365 x average accounts payable / cost of revenue.
Cash conversion cycle405 daysDays inventory + days sales outstanding - days payables.
FCF conversion-48.7%Free cash flow / net income, when net income is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$7.56Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$33.63Revenue / diluted weighted shares.
FCF per share-$3.68Free cash flow / diluted weighted shares.
Operating cash flow per share-$2.85Cash from operations / diluted weighted shares.
Book value per share$23.34Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$19.10Tangible book value / shares outstanding.
Cash per share$3.49(Cash + short-term investments) / shares outstanding.
Payout ratio10.3%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.83BShare price x shares outstanding.
Enterprise value$2.65BMarket cap + total debt - cash - short-term investments.
P/E3.10xMarket cap / net income. Only when net income is positive.
P/S0.70xMarket cap / revenue.
P/B1.00xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.23xMarket cap / tangible book value, when positive.
EV/Sales1.01xEnterprise value / revenue.
EV/EBIT3.26xEnterprise value / operating income, when both are positive.
EV/EBITDA2.77xEnterprise value / EBITDA, when both are positive.
FCF yield-15.7%Free cash flow / market cap.
Earnings yield32.3%Net income / market cap (the inverse of P/E).
Dividend yield3.3%Dividends paid over the period / market cap.
Shareholder yield3.3%(Dividends paid + share buybacks) / market cap.
PEG0.07xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was KENNAMETAL INC's revenue in fiscal 2026?

KENNAMETAL INC reported revenue of $2.36B for fiscal 2026, 19.8% higher than the year before.

Was KENNAMETAL INC profitable in fiscal 2026?

Yes. Net income was $342.4M, a net margin of 14.5%.

How much free cash flow did KENNAMETAL INC generate in fiscal 2026?

Cash from operations of $4.0M minus capital expenditures of $76.9M left free cash flow of -$80.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KENNAMETAL INC